Get all your news in one place.
100’s of premium titles.
One app.
Start reading
The Hindu
The Hindu
National
Special Correspondent

Newborn with COVID-19, lung scarring treated in city

Doctors of Kanchi Kamakoti CHILDS Trust Hospital (KKCTH) have treated a newborn who was diagnosed with COVID-19 pneumonia and went on to develop lung fibrosis and eye complications.

Doctors said the baby girl was born four weeks before the expected date of delivery to a 23-year-old woman, who had tested positive for COVID-19 a week prior to delivery and remained symptom-free at the time of delivery. The baby’s birth weight was 2.4 kg and was admitted in a government hospital in Andhra Pradesh.

The baby developed fever and breathlessness after a week and was referred to a private hospital in Nellore. She tested positive for COVID-19 and was referred to the KKCTH. The CT scan was suggestive of pneumonia. Her inflammatory markers were high.

N. Chandrakumar, head of the Department of Neonatology, KKCTH, said the baby was treated with steroids and intravenous immunoglobulin. “She required ventilator support for three weeks before successful extubation to lesser modes of respiratory support. Despite no requirement for oxygen support, she continued to remain breathless and could not be fed orally,” he said.

A CT scan showed pulmonary fibrosis with residual ground glass opacities, suggestive of post-COVID infection-related lung fibrosis. The baby had features of brain involvement in the MRI scan that could be related to COVID-19 and her eyes developed retinopathy of prematurity (ROP). The ROP was severe enough to require laser treatment, he said.

The baby had been weaned off the ventilator and would be discharged soon, he added.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.